UBS Group’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.38M | Buy |
|
|||||
|
2025
Q2 | $4.37M | Sell |
|
|||||
|
2025
Q1 | $5.22M | Buy |
|
|||||
|
2024
Q4 | $4.5M | Buy |
|
|||||
|
2024
Q3 | $739K | Sell |
|
|||||
|
2024
Q2 | $602K | Sell |
|
|||||
|
2024
Q1 | $2.11M | Buy |
|
|||||
|
2023
Q4 | $1.91M | Buy |
|
|||||
|
2023
Q3 | $664K | Sell |
|
|||||
|
2023
Q2 | $1.08M | Sell |
|
|||||
|
2023
Q1 | $1.56M | Sell |
|
|||||
|
2022
Q4 | $2.91M | Buy |
|
|||||
|
2022
Q3 | $494K | Sell |
|
|||||
|
2022
Q2 | $808K | Sell |
|
|||||
|
2022
Q1 | $4.34M | Buy |
|
|||||
|
2021
Q4 | $3.81M | Buy |
|
|||||
|
2021
Q3 | $3.21M | Buy |
|
|||||
|
2021
Q2 | $147K | Sell |
|
|||||
|
2021
Q1 | $995K | Buy |
|
|||||
|
2020
Q4 | $81K | Buy |
|
|||||
|
2020
Q3 | $11K | Sell |
|
|||||
|
2020
Q2 | $103K | Sell |
|
|||||
|
2020
Q1 | $104K | Sell |
|
|||||
|
2019
Q4 | $144K | Buy |
|
|||||
|
2019
Q3 | $112K | Buy |
|
|||||
|
2019
Q2 | $39K | Buy |
|
|||||
|
2019
Q1 | $8K | Sell |
|
|||||
|
2018
Q4 | $21K | Buy |
|
|||||
|
2018
Q3 | $30K | Buy |
|
|||||
|
2018
Q2 | $28K | Buy |
|
|||||
|
2018
Q1 | $17K | Sell |
|
|||||
|
2017
Q4 | $29K | Buy |
|
|||||
|
2017
Q3 | $31K | Sell |
|
|||||
|
2017
Q2 | $40K | Sell |
|
|||||
|
2017
Q1 | $57K | Sell |
|
|||||
|
2016
Q4 | $46K | Sell |
|
|||||
|
2016
Q3 | $56K | Buy |
|
|||||
|
2016
Q2 | $94K | Sell |
|
|||||
|
2016
Q1 | $337K | Buy |
|
|||||
|
2015
Q4 | $22K | Buy |
|